Article
A germline gain-of-function mutation in Ptpn11 (Shp-2) phosphatase induces myeloproliferative disease by aberrant activation of hematopoietic stem cells.
Blood - 4 Nov 2010
Xu Dan, Wang Siying, Yu Wen-Mei, Chan Gordon, Araki Toshiyuki, Bunting Kevin D, Neel Benjamin G, Qu Cheng-Kui
Abstract excerpt
Germline and somatic gain-of-function mutations in tyrosine phosphatase PTPN11 (SHP-2) are associated with juvenile myelomonocytic leukemia (JMML), a myeloproliferative disease (MPD) of early childhood. The mechanism by which PTPN11 mutations induce this disease is not fully understood. Signaling partners that mediate the pathogenic effects of PTPN11 mutations have not been explored. Here we report that germ line...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
